Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.3390
-0.0010 (-0.29%)
At close: Dec 5, 2025, 4:00 PM EST
0.3325
-0.0065 (-1.92%)
After-hours: Dec 5, 2025, 6:18 PM EST

Akari Therapeutics, Market Cap

Akari Therapeutics, has a market cap or net worth of $12.12 million as of December 5, 2025. Its market cap has decreased by -55.74% in one year.

Market Cap
12.12M
Enterprise Value
11.85M
1-Year Change
-55.74%
Ranking
Category
Stock Price
$0.34

Market Cap Chart

Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $12.12M, a decrease of -95.84%. That is a compound annual growth rate of -26.81%.

History

DateMarket Cap% Change
Dec 4, 202512.15M-62.37%
Dec 31, 202432.30M83.11%
Dec 29, 202317.64M-49.58%
Dec 30, 202234.98M-51.00%
Dec 31, 202171.40M0.31%
Dec 31, 202071.18M93.60%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 904.62B
Johnson & Johnson 486.51B
AbbVie 399.57B
UnitedHealth Group 299.75B
AstraZeneca 280.82B
Novartis AG 255.15B
Merck & Co. 247.51B
Abbott Laboratories 217.50B
Market Cap Rankings